newsfilter
← Latest News
GlobeNewswire·

TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (NASDAQ:TLC, TWO: 4152))), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that